Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series

Fig. 2

Outcomes of specific ocular treatment options used for eyelid complications in sixteen patients with plasma cell disorders on proteasome inhibitor therapy. A stacked bar graph demonstrating the number of episodes of chalazia and blepharitis that resolved or persisted based on specific ocular therapies such as hot compresses, topical antibiotics and/or steroids, oral antibiotics, or oral steroids. Topical antibiotic and/or steroid drops and ointments used included tobramycin, tobramycin/dexamethasone, azithromycin, erythromycin, bacitracin, loteprednol, and dexamethasone. Systemic antibiotics used included doxycycline, cephalexin, gentamicin, and ciprofloxacin. Oral steroids used included methylprednisolone

Back to article page